We are monitoring the impact of COVID-19 on Europe Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2825
Share on
Share on

Europe Sepsis Diagnostics Market Research Report – Segmented By Pathogen, Product , Technology, Method , Usability, & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2825
Pages: 145

Europe Sepsis Diagnostics Market Size (2021 to 2026)

The size of the sepsis diagnostics market in Europe was valued at USD 430.63 Million in 2021 and is estimated to be worth USD 645.43 Million by 2026, growing at a CAGR of 8.43% during the forecast period.

Sepsis Diagnosis is on the rise as the incidence rate, and prevalence of sepsis are on the rise. Sepsis is a severe illness condition occurring when the body reacts to a bacterial, viral, fungal, or parasitic foreign body infection. It is one of the most death-causing diseases in hospitals. The contamination leads to organ dysfunction or failure and systemic inflammation. Its symptoms are hypertension, high body temperature, shivering, and elevated heart rate. The increasing prevalence of the disease and its fatal effects have stimulated its growth.

An increase in sepsis incidences with the growing regulatory approval and the development of technologically improved diagnostic solutions are likely to be the major drivers accelerating the growth rate of the European sepsis diagnostics market expansion. In addition, the increase in financing for sepsis-related research activities, an increase in the number of sepsis procedures, with the rise in the prevalence of antibiotic-resistant bacterial strains are expected to propel the market growth.

On the other hand, an increase in the incidence of diagnostic solutions, spreading awareness with the help of government initiatives, an increase in the number of pneumonia cases, and market key players are other factors driving the market growth.

The key factors obstructing the sepsis diagnostics market growth in the European region are the lack of standard protocols for treating sepsis in some countries and the lack of awareness about the complications of sepsis diagnostics. Also, a shortage of skilled professionals in the healthcare industry has always been a significant challenge among the countries. Furthermore, sepsis diagnostics also cost a considerable amount, and it also restricts the market’s growth.

Impact of COVID-19 on the European sepsis diagnostics market:

The covid 19 pandemics have proven to the havoc on the healthcare industry, and sepsis diagnostics is no excuse. The covid 19 pandemics have increased the competition for hospital beds, and people getting admitted to hospitals have increased. In turn, the chances of encountering sepsis due to hospital have also increased. Therefore, the need for sepsis diagnostics has been increasing and is expected to increase further in the near future. The supply chain, however, is adversely affected and expected to improve after the restrictions are removed.

This research report has been segmented and sub-segmented the European Sepsis Diagnostics Market into the following categories:

By Pathogen:

  • Bacterial Sepsis    
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis        
  • Other Pathogen Infections

By Product:

  • Instruments          
  • Blood Culture Media          
  • Assay Kits & Reagents       
  • Software  

By Technology:

  • Microbiology         
  • Molecular Diagnostics       
  • Immunoassays    
  • Flow Cytometry  
  • Other Technologies

By Method:

  • Conventional Diagnostics
  • Automated Diagnostics

By Usability:

  • Laboratory Testing              
  • Point-of-Care Testing

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European sepsis diagnostics market accounted for a substantial share in the global market in 2020. Among various nations of Europe, the German sepsis diagnostics market is forecasted to grow at a promising CAGR and play a leading role. In Germany, sepsis is a prevalent and often deadly disease in pediatric patients, especially in newborns and children suffering from more than one illness at the same time.

The UK sepsis diagnostics market is estimated to register a healthy CAGR during the forecast period. However, according to a new study in the UK, sepsis kills more people than breast and pancreatic cancer. It is because of the staff shortage and overcrowding of the hospitals which led to an increase in the sepsis death rate, and according to the Sepsis Trust, there are around 245,783 cases in the UK each year in that half of the people including die because of sepsis and mostly suffer permanently.

KEY MARKET PLAYERS:

Some of the leading companies operating in the European Sepsis Diagnostics market profiled in the report are bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  2. Europe Bacterial Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  3. Europe Fungal Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  4. Europe Other Pathogen Infections Market By Region, From 2021 to 2026 (USD Million)
  5. Europe Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  6. Europe Instruments Market By Region, From 2021 to 2026 (USD Million)
  7. Europe Blood Culture Media Market By Region, From 2021 to 2026 (USD Million)
  8. Europe Assay Kits and Reagents Market By Region, From 2021 to 2026 (USD Million)
  9. Europe Software Market By Region, From 2021 to 2026 (USD Million)
  10. Europe Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  11. Europe Molecular Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  12. Europe Microbiology Market By Region, From 2021 to 2026 (USD Million)
  13. Europe Immunoassay Market By Region, From 2021 to 2026 (USD Million)
  14. Europe Flow Cytometry Market By Region, From 2021 to 2026 (USD Million)
  15. Europe Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  16. Europe Conventional Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  17. Europe Automated Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  18. Europe Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  19. Europe Laboratory Testing Market By Region, From 2021 to 2026 (USD Million)
  20. Europe Point-of-Care Testing Market By Region, From 2021 to 2026 (USD Million)
  21. U.K. Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  22. U.K. Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  23. U.K. Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  24. U.K. Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  25. U.K. Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  26. Germany Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  27. Germany Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  28. Germany Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  29. Germany Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  30. Germany Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  31. France Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  32. France Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  33. France Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  34. France Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  35. France Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  36. Italy Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  37. Italy Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  38. Italy Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  39. Italy Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  40. Italy Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  41. Spain Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  42. Spain Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  43. Spain Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  44. Spain Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  45. Spain Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample